Who we are

Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies- one of the most cutting-edge and highly promising areas of drug development. The company is built on a proprietary modular technology platform optimized for the delivery of radioisotopes to selectively destroy tumor cells while sparing healthy cells. Abdera is using this platform to enable the rapid development of a broad range of safe and efficacious therapies serving cancer patients with limited treatment options.

Abdera Therapeutics is growing rapidly and seeking key new team members who thrive at the cutting-edge of innovation. Come join us and be a part of the ground-breaking team set to unlock the power of targeted radiotherapy!

What we look for

At Abdera Therapeutics, we are looking for curious and committed individuals who are ready for the opportunity to transform the way people living with cancer can be treated. We are devoted to advancing novel treatment options that offer new hope to families facing devastating diagnoses. We are in search of team members who work collaboratively with a diverse group of colleagues, respectfully engaging one another while collectively and inclusively tackling any challenges we may face. We are building an exciting and fast paced company passionate about discovering and developing tomorrow's most innovative cancer therapies.

Salary Range: CAD$ 135K - 175K
Please include a cover letter when you apply

Principal Responsibilities

• Scientific lead for in vivo pharmacology, PK/BD and toxicology studies.
• Lead preclinical studies in-house and at contract research organizations (CROs) to support candidate selection and advance development programs and platform innovation.
• Mentor and train team members in the pharmacology group.
• Collaborate with cross-functional teams to provide scientific input and design, execute, and interpret studies.
• Write and review study protocols and reports, analyze results, present findings, and contribute to authoring manuscripts and regulatory filings.
• Identify and implement new pharmacology models, technologies, and strategies to develop targeted cancer radiotherapies.

Qualifications, Education & Experience

PhD in Pharmacology, Oncology, Pharmaceutical Sciences, Toxicology or a related discipline with a minimum of 5 years relevant experience or an equivalent combination of industry experience in preclinical drug discovery and development

Skills & Abilities

• Demonstrated advanced knowledge and hands-on experience in relevant in vivo oncology/pharmacology models.
• Prior experience conducting in vivo studies with CROs, IND-enabling studies and supporting IND submissions.
• R&D experience with antibody-based therapeutics, radiopharmaceuticals and in vivo imaging studies is an asset.
• Proven ability to work collaboratively in a cross-functional team and develop effective relationships with key partners.
• Proven ability to lead and manage concurrent deliverables in a fast-paced, milestone-driven environment.
• Experience with supervising and mentoring research staff.
• Excellent communication and presentation skills.

Abdera is an equal opportunity employer that is committed to diversity and inclusion in the workplace. At Abdera, we prohibit harassment of any kind and any form of discrimination including but not limited to discrimination based on race, color, sex, religion, marital status, sexual orientation, national origin, disability, veteran status, genetic information, pregnancy, or any other protected characteristic as outlined by federal, state, or local laws.

Powered by JazzHR

d8g3JV7C68